TNYA

Tenaya Therapeutics (TNYA)

Tenaya Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TNYA

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/05/15	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/05/15	05 : 05	GlobeNewswire Inc.	Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/05/03	06 : 00	GlobeNewswire Inc.	Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/03/19	05 : 05	GlobeNewswire Inc.	Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/03/18	21 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/28	09 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/28	06 : 30	GlobeNewswire Inc.	Tenaya Therapeutics to Participate in Upcoming March Investor Conferences	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/26	22 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Announces Publication of Preclinical HDAC6 Inhibitor Data for Heart Failure with Preserved Ejection Fraction in Nature Communications	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/17	10 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/17	10 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/09	07 : 25	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/08	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/08	22 : 00	GlobeNewswire Inc.	Tenaya Therapeutics Announces Pricing of Underwritten Offering	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/02/01	06 : 11	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TNYA	Tenaya Therapeutics Inc
2024/01/03	22 : 30	GlobeNewswire Inc.	Tenaya Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/11/22	06 : 30	GlobeNewswire Inc.	Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/11/09	06 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/11/09	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/11/09	06 : 05	GlobeNewswire Inc.	Tenaya Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/10/26	21 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/10/09	21 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/10/05	21 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/10/03	06 : 30	GlobeNewswire Inc.	Tenaya Therapeutics Publishes Preclinical Data in Circulation Highlighting the Clinical Potential of Cellular Reprogramming for Cardiac Regeneration	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/09/22	05 : 05	GlobeNewswire Inc.	Tenaya Therapeutics to Present Data for TN-301 and TN-201 at Upcoming Medical Conferences	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/09/01	05 : 05	GlobeNewswire Inc.	Tenaya Therapeutics to Participate at the 21st Annual Morgan Stanley Global Healthcare Conference	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/08/19	07 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/08/17	10 : 10	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/08/10	05 : 26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNYA	Tenaya Therapeutics Inc
2023/08/10	05 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNYA	Tenaya Therapeutics Inc